subgroup of
trial)
→
CapableOf
→
assess tolerability
| Typicality: | 0.491 |
| Saliency: | 0.565 |
| in that patient population | 4 | other |
| phase trial → assess → tolerability | 4 |
| phase trial → evaluate → tolerability | 4 |
| negative | neutral | positive |
| 0.018 | 0.844 | 0.138 |
| Raw frequency | 8 |
| Normalized frequency | 0.565 |
| Modifier score | 0.500 |
| Perplexity | 109.595 |